查詢結果分析
來源資料
相關文獻
- Clinical Experience with the Ahmed Glaucoma Valve Implant in Complicated Glaucoma
- Carteolol (Arteoptic[feb9])之臨床評估及心血管作用--內因性擬交感神經作用之探討
- Timoptol-XE[feb9] 及Timoptol[feb9] 用於青光眼或高眼壓症病人之比較性研究
- 後房注射Alpha-chymotrypsin誘發之高眼壓兔眼模式之房水動力學變化
- 眼科常用之三種散瞳劑對學童眼壓之影響
- Short-term Intraocular Pressure Dynamics after Trabeculectomy
- Intraocular Pressure Changes During Hemodialysis
- Atracurium Used as Pretreatment Agent of Inhibit Succinylcholine Induced Increased Intraocular Pressure
- Aqueous Inflow in Normal Tension Glaucoma
- 0.1 % Indomethacin 對氬氣雷射虹膜穿孔術後眼壓的影響
頁籤選單縮合
題 名 | Clinical Experience with the Ahmed Glaucoma Valve Implant in Complicated Glaucoma=使用Ahmed青光眼瓣膜於複雜性青光眼之臨床經驗 |
---|---|
作 者 | 吳秀琛; 黃朝銘; 林耕國; | 書刊名 | 長庚醫學 |
卷 期 | 26:12 2003.12[民92.12] |
頁 次 | 頁904-910 |
分類號 | 416.748 |
關鍵詞 | Ahmed青光眼瓣膜; 眼壓; 眼壓高原期; 頑固型青光眼; Ahmed glaucoma valve; Intraocular pressure; Hypertensive phase; Refractory glaucoma; |
語 文 | 英文(English) |
中文摘要 | 背景:本文旨在評估運用單向瓣膜原理的房水引流管,Ahmed青光眼瓣膜,於複雜性青光眼的臨床結果。 方法:回顧性連續收集因他種方法困難處理而接受Ahmed青光眼瓣膜,且追蹤至少6個月之頑固型青光眼病患。若術後6個月內眼壓高於或等於22毫米汞柱則被定義為眼壓高原期。本文共收集19位病患之19隻眼睛。 結果:術前平均眼壓為32.1±6.9毫米汞柱;平均使用藥物為3.8±1.0種。術後平均眼壓分別為:7.8±2.2毫米汞柱(第1天),11.3±4.4毫米汞柱(第一週),19.1±7.7毫米汞柱(1個月),16.5±6.4(3個月),和17.5±0.7(6個月)。共有12位病人(63.2%)出現眼壓高原期;其中9位病人發生於術第1個月,3位病人發生於術後第2個月。到了術後6個月仍有11位人需要使用青光眼藥物,平均使用藥物為1.0種。術後併發症包括:前房出血(1位),脈絡膜下積水(2位),虹彩堵塞引流管(1位),濾泡纖維化(3位,和角膜移植失敗(1位)等。術後暫時性眼壓過低之患者均於術後一週內自行恢復。 結論:本研究結果顯示Ahmed青光眼瓣膜運用在複雜或青光眼是安全和有效的方法。眼壓高原以多在術後第1個月和第2個月出現。 |
英文摘要 | Backgorund: To assess clinical outcomes of the Ahmed glaucoma valve implant, an aqueous shunting device with a unidirectional valve mechanism, in eyes with refractory glaucoma. Methods: Consecutive patients with tractable glaucoma who underwent Ahmed glaucoma value insertion were retrospectively reviewed. Only patients with a minimum of 6 months of follow-up wee included. The presence of intraocular pressure (IOP)?22 mmHg in the first 6 postoperative months was defined as a hypertensive phase (HP). This study included 19 eyes in 19 patients. Results: The mean preoperative IOP was 32.1±6.9 mmHg, with medication (mean times medication administered, 3.8±1.0; range, 0-3). The mean postoperative IOP was 7.8±2.2 mmHg on day 1, 11.3±4.4 mmHg at 1 week, 19.1±7.7 mmHg at 1 month, 16.5±6.4 mmHg at 3 month and 3 patients at 2 months after the operation. At the end of months of follow-up, 11 patients (57.9%) who had exhibited the HP required additional anti-glaucoma medication to control the IOP (mean times medication was administered, 1.0±1.1; range, 0-2). Complications associated with the valve included hyphema in 1 case, choroidal effusion in 2 cases, iris plugging of the tube in 1 case, bleb encapsulation in 3 cases, and PK graft failure in 1 case. Postoperative hypotony resolved within 1 week. Conclusion: The Ahmed glaucoma valve implant was safe and effective in this series. The hypertensive phase peaked in the first to second months after surgery. |
本系統中英文摘要資訊取自各篇刊載內容。